BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN CENTRAL AMERICA

被引:0
|
作者
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mogollon, Mayorga W. [2 ]
Chavez, M. A. [3 ]
Patino, A. [1 ]
Herran, S. E. [1 ]
Marrugo, R. [1 ]
机构
[1] Bayer, Bogota, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, San Jose, Costa Rica
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE311
引用
收藏
页码:S116 / S116
页数:1
相关论文
共 50 条
  • [1] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S74 - S74
  • [2] BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) USING THE STANDARD OF CARE IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S160
  • [3] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S159 - S159
  • [4] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN PERU
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mayorga, Mogollon W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S137 - S137
  • [5] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S95 - S95
  • [6] Delayed Chronic Kidney Disease (CKD) Diagnosis in Type 2 Diabetes (T2D)
    Harindhanavudhi, Tasma
    Freese, Rebecca L.
    Caramori, Luiza
    [J]. DIABETES, 2021, 70
  • [7] Physicians' Chronic Kidney Disease (CKD) Awareness over Time in Type 2 Diabetes (T2D)
    Schempf, John
    Freese, Rebecca L.
    Caramori, Luiza
    Harindhanavudhi, Tasma
    [J]. DIABETES, 2020, 69
  • [8] BURDEN OF CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES USING THE STANDARD OF CARE IN COLOMBIA
    Mayorga, W.
    Lopez, D. S.
    Alvarado, A.
    Marrugo, R.
    Zuluaga, J. R.
    Patino, A.
    Herran, S. E.
    Lopez, C.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S376 - S376
  • [9] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [10] AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D)
    Chu, Lisa
    Bhogal, Sanjit K.
    Lin, Peter
    Steele, Andrew
    Fuller, Mark
    Ciaccia, Antonio
    Abitbol, Alexander
    [J]. CANADIAN JOURNAL OF DIABETES, 2022, 46 (05) : 464 - 472